|
2
|
19
|
5yklA |
Antimicrobial peptide ay1c designed from the skin secretion of chinese odorous frogs |
|
2
|
18
|
5ykkA |
Antimicrobial peptide andersonin-y1 (ay1) |
|
2
|
19
|
5ykqA |
Designed peptide cay1 from odorrana andersonii skin secretion |
|
1
|
12
|
5z5wA |
Vfr12 in complex with lps micelles |
|
2
|
18
|
5z5xA |
Hvf18 in complex with lps micelles |
|
55
|
209
|
5yigA |
Crystal structure of streptococcus pneumonia pare with inhibitor |
|
0
|
21
|
5xoaA |
Thanatin m21f in complex with lps |
|
0
|
21
|
5xo3A |
Thanatin m21f free |
|
1
|
21
|
5xo9A |
Thanatin in presence of lps |
|
0
|
17
|
5xrxA |
Efk17da structure in microgel maa60 |
|
0
|
21
|
5xokA |
Thanatin y10m21aa in complex with lps |
|
1
|
32
|
4e83A |
Crystal structure of human alpha-defensin 5, hd5 (leu29nle mutant) |
|
3
|
32
|
4e82A |
Crystal structure of monomeric variant of human alpha-defensin 5, hd5 (glu21eme mutant) |
|
1
|
32
|
4e86A |
Crystal structure of human alpha-defensin 5, hd5 (leu29aba mutant) |
|
11
|
46
|
4ab0A |
X-ray crystal structure of nicotiana alata defensin nad1 |
|
13
|
47
|
4aazA |
X-ray structure of nicotiana alata defensin 1 nad1 |
|
41
|
176
|
3tf6A |
Crystal structure of neutrophil gelatinase-associated lipocalin (c87s mutant) in complex with europium and the siderophore analog tren(cam)(1,2-hopo)2 |
|
41
|
175
|
3t1dA |
The mutant structure of human siderocalin w79a, r81a, y106f bound to enterobactin |
|
0
|
21
|
5xolA |
Thanatin r13r14aa in complex with lps |
|
4
|
33
|
6dmmA |
Crystal structure of the g23a mutant of human alpha defensin hnp4. |
|
2
|
12
|
2md4A |
Fragment based approach and binding behavior of lfampinb with lipopolysaccharide: biophysical aspects |
|
0
|
21
|
5xo4A |
Free thanatin at 298k |
|
7
|
22
|
2mcvA |
Solid-state nmr structure of piscidin 1 in aligned 1:1 phosphatidylethanolamine/phosphoglycerol lipid bilayers |
|
0
|
21
|
5xo5A |
Free thanatin y10a m21a |
|
0
|
15
|
1qx9A |
Structure of a cyclic indolicidin peptide derivative with higher charge |
|
7
|
21
|
5xdjA |
Esculentin-1a(1-21)nh2 |
|
2
|
20
|
5x3lA |
Solution structure of a novel antimicrobial peptide, p1, from jumper ant myrmecia pilosula |
|
13
|
47
|
5vypA |
Crystal structure of the plant defensin nsd7 bound to pip2 |
|
6
|
20
|
5v1eA |
Suboptimization of a glycine rich peptide allows the combinatorial space exploration for designing novel antimicrobial peptides |
|
0
|
21
|
5v11A |
Solution structure of arenicin-3 synthetic analog. |
|
0
|
21
|
5v0yA |
Solution structure of arenicin-3. |
|
8
|
23
|
5u9xA |
Ocellatin-lb2 |
|
6
|
22
|
5ua6A |
Ocellatin-lb1, solution structure in sds micelle by nmr spectroscopy |
|
8
|
22
|
5u9qA |
Ocellatin-lb1 |
|
7
|
22
|
5u9vA |
Ocellatin-lb1, solution structure in dpc micelle by nmr spectroscopy |
|
1
|
18
|
5ui6A |
Solution nmr structure of lasso peptide acinetodin |
|
5
|
33
|
5ujrA |
Nmr solution structure of the two-component bacteriocin cbnxy |
|
6
|
25
|
5u9yA |
Ocellatin-f1 |
|
8
|
23
|
5ua7A |
Ocellatin-lb2, solution structure in sds micelle by nmr spectroscopy |
|
11
|
44
|
5ukzA |
Nmr solution structure of chemically synthesized antilisterial pediocin pa-1 m31l analog. |
|
5
|
29
|
5ujqA |
Nmr solution structure of the two-component bacteriocin cbnxy |
|
1
|
19
|
5ui7A |
Solution nmr structure of lasso peptide klebsidin |
|
9
|
34
|
5nnmA |
The crystal structure of dimeric ll-37 |
|
12
|
34
|
5nnkA |
The structure of ll-37 crystallized in the presence ldao |
|
14
|
34
|
5nmnA |
Atomic resolution structure of ll-37 in a monomeric state |
|
12
|
34
|
5nntA |
The dimeric structure of ll-37 crystallized in dpc |
|
5
|
16
|
5mmlA |
Hyl-20k |
|
46
|
213
|
5i7kA |
Crystal structure of human splunc1 dolphin mutant d1 (g58a, s61a, g62e, g63d, g66d, i67t) |
|
5
|
25
|
5h2sA |
Solution structure of tilapia piscidin 4 (tp4) from oreochromis niloticus |
|
17
|
63
|
5e5tA |
Quasi-racemic snakin-1 in p1 after radiation damage |
